m+Medelevator.RU
← Поиск публикаций
Clinical immunology (Orlando, Fla.) · 2015

Lack of IL7Rα expression in T cells is a hallmark of T-cell immunodeficiency in Schimke immuno-osseous dysplasia (SIOD).

СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Sanyal Mrinmoy, Morimoto Marie, Baradaran-Heravi Alireza, Choi Kunho, Kambham Neeraja, Jensen Kent, Dutt Suparna, Dionis-Petersen Kira Y, Liu Lan Xiang, Felix Katie, Mayfield Christy, Dekel Benjamin, Bokenkamp Arend, Fryssira Helen, Guillen-Navarro Encarna, Lama Giuliana, Brugnara Milena, Lücke Thomas, Olney Ann Haskins, Hunley Tracy E, Polat Ayse Ipek, Yis Uluc, Bogdanovic Radovan, Mitrovic Katarina, Berry Susan, Najera Lydia, Najafian Behzad, Gentile Mattia, Nur Semerci C, Tsimaratos Michel, Lewis David B, Boerkoel Cornelius F

Аннотация

Schimke immuno-osseous dysplasia (SIOD) is an autosomal recessive, fatal childhood disorder associated with skeletal dysplasia, renal dysfunction, and T-cell immunodeficiency. This disease is linked to biallelic loss-of-function mutations of the SMARCAL1 gene. Although recurrent infection, due to T-cell deficiency, is a leading cause of morbidity and mortality, the etiology of the T-cell immunodeficiency is unclear. Here, we demonstrate that the T cells of SIOD patients have undetectable levels of protein and mRNA for the IL-7 receptor alpha chain (IL7Rα) and are unresponsive to stimulation with IL-7, indicating a loss of functional receptor. No pathogenic mutations were detected in the exons of IL7R in these patients; however, CpG sites in the IL7R promoter were hypermethylated in SIOD T cells. We propose therefore that the lack of IL7Rα expression, associated with hypermethylation of the IL7R promoter, in T cells and possibly their earlier progenitors, restricts T-cell development in SIOD patients.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты